槍魁和阿賊在法國挻守鋪的呀

，咋到了大金國就犯事了呢？

 

https://www.sciencedirect.com/science/article/pii/S1477893920302179 

Methods

We retrospectively report on 1061 SARS-CoV-2 positive tested patients treated with HCQ (200 mg three times daily for ten days) + AZ (500 mg on day 1 followed by 250 mg daily for the next four days) for at least three days. Outcomes were death, clinical worsening (transfer to ICU, and >10 day hospitalization) and viral shedding persistence (>10 days).

Results

A total of 1061 patients were included in this analysis (46.4% male, mean age 43.6 years – range 14–95 years). Good clinical outcome and virological cure were obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage was observed in 47 patients (4.4%) and was associated to a higher viral load at diagnosis (p?<?.001) but viral culture was negative at day 10. All but one, were PCR-cleared at day 15. A poor clinical outcome (PClinO) was observed for 46 patients (4.3%) and 8 died (0.75%) (74–95 years old). All deaths resulted from respiratory failure and not from cardiac toxicity. Five patients are still hospitalized (98.7% of patients cured so far). PClinO was associated with older age (OR 1.11), severity at admission (OR 10.05) and low HCQ serum concentration. PClinO was independently associated with the use of selective beta-blocking agents and angiotensin II receptor blockers (p?<?.05). A total of 2.3% of patients reported mild adverse events (gastrointestinal or skin symptoms, headache, insomnia and transient blurred vision).

Conclusion

Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients.

 

 

附：學說東北話“守鋪（pu 1長聲)”

https://zhidao.baidu.com/question/397190901905353165.html

 

所有跟帖： 

• 美國心肌梗塞的病人比國內多很多，會不會他們有心髒基礎疾病的人也多，羥氯喹一用，死亡的人也多，統計 -誌在千裏- ♀ (260 bytes) () 05/12/2020 postreply 12:55:51

• 報道說，這次新冠病患不僅會血氧下降，還並發blood clot，其中包括不少沒有這類病史年輕人。 -pickshell- ♀ (0 bytes) () 05/12/2020 postreply 14:36:57